Top Stories

Luxturna rival emerges

Staff reporters 12/04/2024

Promising interim results from the phase 2 trial of Beacon Therapeutics AGTC-501, a gene therapy for patients with retinitis pigmentosa, present a challenger to Spark Therapeutics’ Luxturna.

Patients needed for castor oil study

Staff reporters 10/04/2024

Following the success of a University of Auckland-led pilot study examining castor oil as a treatment for dry eye disease, researchers are now looking for 90-plus participants for a larger, more robust study.

Eyewear is often considered a means of self-expression, empowering individuals and boosting their confidence. But glasses can be highly gender-specific, which can make some patients feel uncomfortable shopping for them.

Interventional glaucoma: the future is now

Drs Divya Perumal and Shenton Chew 09/04/2024

Interventional glaucoma is reshaping the management of glaucoma, write Drs Perumal and Chew, sharing insights from a recent international round table meeting. 


AMD-cancer link?

Staff reporters 11/04/2024

Glaucoma eye drop for myopia?

Staff reporters 10/04/2024

Oversized, elegant, Morel

Staff reporters 09/04/2024

Eye dropper launched into orbit

Staff reporters 08/04/2024

Bridging the gap

Staff reporters 07/04/2024

Editor's Choice

Addressing staffing gaps with a virtual CFO

David Pearson and Michael Nes 12/04/2024

Uveitis research review

Dr Jo Sims 02/04/2024

Current state of keratoconus management in New Zealand

By Drs Lize Angelo and Akilesh Gokul 01/04/2024

Myopia management applications

Grant Hannaford 14/03/2024


DMO: looking beyond HbA1c

Dr Leo Sheck 11/04/2024

RANZCO NZ 2024 – meet the speakers

Drew Jones 08/04/2024

NZOSS 2024: more than eyes!

Hector Leong, New Zealand Optometry Student Society president 20/03/2024


NZAO to progress scope change

Drew Jones 01/04/2024

Enhanced LASIK for ‘HD’ vision

Staff reporters 25/03/2024

The damage that drops can do!

Dr Alex Ioannidis 14/03/2024